Crohn's disease in childhood is a chronic relapsing and remitting condition that can significantly impact normal growth and development. This influences choice of both initial and ongoing management. The goal of therapy is to induce and maintain remission with minimal side effects. Enteral nutrition is effective in active disease and will induce disease remission in most cases avoiding corticosteroid use. The high frequency of relapse means additional immunosuppressive therapies are usually required but nutrition remains a key priority as part of the subsequent management strategy.
Get full access to this article
View all access options for this article.
References
1.
1. Bremner AR, Beattie RM. Therapy of Crohn's disease in childhood. Expert Opinion In Pharamacother.2002;3:809–825.
2.
2. Savage MO, Beattie RM, Camacho-Hubner C, et al. Growth in Crohn's disease. Acta Paediatrica.1999;88:89–92.
3.
3. Thomas AG, Taylor F, Miller V. Dietary intake and nutritional treatment in childhood Crohn's disease. J Pediatr Gastroenterol Nutr.1993;17:75–81.
4.
4. Griffiths AM, Nguyen AM, Smith C, et al. Growth and clinical course of children with Crohn's disease. Gut.1993;34:939–943.
5.
5. Hildebrand H, Karlberg J, Kristiansson B. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr.1994;18:165–173.
6.
6. Lipson AB, Savage MO, Davies PS, et al. Acceleration of linear growth following intestinal resection for Crohn disease. Eur. J. Pediatr.1990;149:687–690.
7.
7. Davies G, Evans CM, Shand WS, Walker-Smith JA. Surgery for Crohn's disease in childhood: influence of site of disease and operative procedure on outcome. Br J Surg.1990;77:891–894.
8.
8. Murch SH, Lamkin VA, Savage MO, et al. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut.1991;32:913–917.
9.
9. Thomas AG, Miller V, Taylor F, et al. Whole body protein turnover in childhood Crohn's disease. Gut.1992;33:675–677.
10.
10. Thomas AG, Holly JM, Talyor F, Miller V. Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease. Gut.1993;34:944–947.
11.
11. Beattie RM, Camacho-Hubner C, Wacharasindhu S, et al. Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease. Clin Endocrinol.1998;49:483–489.
12.
12. Markowitz J, Grancher K, Rosa J, et al. Growth failure in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr.1993;16:373–380.
13.
13. Axelsson CJ, Arnum S. Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease. Scand J Gastroenterol.1977;12:89–95.
14.
14. O'Morain C, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J.1984;288:1859–1862.
15.
15. Kirschner BS, Klich JR, Kalman SS, et al. Reversal of growth retardation in Crohn's disease with therapy emphasizing oral nutritional restitution. Gastroenterology.1981;80:10–15.
16.
16. O'Morain C, Segal AM, Levi AJ, Valman HB. Elemental diet in acute Crohn's disease. Arch Dis Child.1983;58:44–47.
17.
17. Sanderson IR, Udeen S, Davies PS, et al. Remission induced by an elemental diet in small bowel Crohn's disease. Arch Dis Child.1987;62:123–127.
18.
18. Papadopoulou A, Rawashdeh MO, Brown GA, et al. Remission following an elemental diet or prednisolone in Crohn's disease. Acta Paediatr.1995;84:79–83.
19.
19. Beattie RM, Schiffrin EJ, Donnet-Hughes A, et al. Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther.1994;8:609–615.
20.
20. Ruuska T, Savilahti E, Maki M, et al. Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr.1994;19:175–180.
21.
21. Fell JM, Paintin M, Arnaud-Battandier F, et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther.2000;14:281–289.
22.
22. Bannerjee K, Camacho-Hubner C, Babinska, et al. Anti-inflammatory and growth stimulating effects precede nutritional restitution during enteral feeding in Crohn's diseaseJ Paed Gastro Nutr.2004;38: 270–275.
23.
23. Afzal NA, Van Der Zaag-Loonen HJ, Arnaud-Battandier F, et al. Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Aliment Pharmacol Ther.2004;20:167–172.
24.
24. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology.1995;108:1056–1067.
25.
25. Fernandez-Banares F, Cabre E, Esteve-Comas M, Gassull MA. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. JPEN J Parenter Enteral Nutr.1995;19:356–364.
26.
26. Wight N, Scott BB, Wright N. Dietary treatment of active Crohn's disease. Br Med J.1997;314:454–455.
27.
27. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for inducing remission of Crohn's disease (Cochrane review). Cochrane Database Syst Rev.2001;3:CD000542.
28.
28. Luvigsson JF, Krantz M, Bodin L, et al. Elemental versus polymeric enteral nutrition in paediatric Crohn's disease. Acta Paediatr.2004;93:327–335.
29.
29. Beattie RM, Bentsen BS, MacDonald TT. Childhood Crohn's disease and the efficacy of enteral diets. Nutrition.1998;14:345–350.
30.
30. Afzal NA, Addai S, Fagbemi A, et al. Refeeding syndrome with enteral nutrition in children: a case report, literature review and clinical guidelines. Clin Nutr.2002;21:515–520.
31.
31. Riordan AM, Hunter JO, Cowan RE, et al. Treatment of active Crohn's disease by exclusion diet: East Anglian multicentre controlled trial. Lancet.1993;342:1131–1134.
32.
32. Rigaud D, Cosnes J, Le Quintrec Y, et al. Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet. Gut.1991;32:1492–1497.
33.
33. Gorard DA, Hunt JB, Payne-James JJ, et al. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut.1993;34:1198–1202.
34.
34. Gonzalez-Huix F, De Leon R, Fernandez-Banares F, et al. Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial. Gut.1993;34:778–782.
35.
35. Teahon K, Bjarnason I, Pearson M, Levi AJ. Ten years' experience with an elemental diet in the management of Crohn's disease. Gut.1990;31:1133–1137.
36.
36. Randell T, Murphy MS. Evaluation of elemental diet therapy as a long-term strategy for managing Crohn's disease in childhood. Arch. Dis. Child.2002;84:A4–A4.
37.
37. Belli DC, Seidman E, Bouthillier L, et al. Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology.1988;94:603–610.
38.
38. Polk DB, Hattner JA, Kerner JA Jr. Improved growth and disease activity after intermittent administration of a defined formula diet in children with Crohn's disease. JPEN J Parenter Enteral Nutr.1992;16:499–504.
39.
39. Wilschanski M, Sherman P, Pencharz P, et al. Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut.1996;38:543–548.
40.
40. Verma S, Holdsworth CD, Giaffer MH. Does adjuvant nutritional support diminish steroid dependency in Crohn disease?Scand J Gastroenterol.2001;36:383–388.
41.
41. Cowan FJ, Warner JT, Dunstan FD, et al. Inflammatory bowel disease and predisposition to osteopenia. Arch Dis Child.1997;76:325–329.
42.
42. Habtezion A, Silverberg MS, Parkes R, et al. Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis.2002;8:87–92.
43.
43. Papaioannou A, Ferko NC, Aadachi JD. All patients with inflammatory bowel disease should have bone density assessment: pro. Inflamm Bowel Dis.2001;7:158–162.
44.
44. Leslie WD. All patients with inflammatory bowel disease should have bone density assessment: con. Inflamm Bowel Dis.2001;7:163–167.
45.
45. Schoon EJ, Blok BM, Geerling BJ, et al. Bone mineral density in patients with recently diagnosed inflammatory bowel disease. Gastroenterology.2000;119:1203–1208.
46.
46. Boot AM, Bouquet J, Krenning EP, et al. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut.1998;42:188–194.
47.
47. Gokhale R, Favus MJ, Karrison T, et al. Bone mineral density assessment in children with inflammatory bowel disease. Gas-troenterology.1998;114:902–911.
48.
48. Scott EM, Gaywood I, Scott BB. Guidelines for Osteoporosis in Coeliac disease and inflammatory bowel disease. British Society of Gastroenterology. Gut.2000;46:i1–i8.
49.
49. Heuschkel RB, Menache CC, Megerian JT, Baird AE. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr.2000;31:8–15.
50.
50. Modigliani R, Mary JY, Simon JF, et al. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology.1990;98:811–818.
51.
51. Landi B, Anh TN, Cortot A, et al. Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gastroenterology.1992;102:1647–1653.
